ArticleFrontiers in pharmacology2025

MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis.

Yuanhao Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.